| |
![]() ![]() |
Preoperative Considerations and Care Training for key personnel should be conducted and arrangements for Therapy Maintenance should be made before a drug delivery system is implanted. (Also see Practice Components for other considerations.) Please refer to the drug package insert for a complete list of warnings, precautions, dosing information and contraindications. Once it has been determined that the patient is going to receive intrathecal drug delivery, the next responsibility is to conduct preoperative care and education. Determining Implant Site Prior to surgery, the clinician should confer with the patient to determine the pump pocket site. The following guidelines may be used in making the determination:
Identifying and Controlling Infections Prior to surgery, it is critical to detect the presence of infection. Laboratory testing (e.g., complete blood count differential and urinalysis) should be conducted one to two days prior to surgery. If the patient shows any sign of infection, the implant should be postponed until the infection is resolved. You may also want to consider treating the patient with pre- and perioperative prophylactic antibiotics.Patient Informed Consent During preoperative care, the patient should be instructed on his/her treatment and personal responsibilities. If you haven't done so already, review the Patient Informed Consent Form and educate the patient regarding its content. By reviewing the Informed Consent Form with a patient, a clinician can ensure that he or she has covered all the critical information regarding the therapy. Primary areas to be covered during preoperative education and the Informed Consent process include:
For more information, see Patient and Family Education. [Top]To see Citations regarding Screening Test and Implant Techniques. . . [Top] |
|
Version b3.01 © Medtronic, Inc. |
|
[an error occurred while processing this directive]
|